⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29288257 | 0.80 | — | — | |
| SCHEMBL3946473 | 0.76 | — | — | |
| SCHEMBL3946475 | 0.76 | — | — | |
| SCHEMBL12971553 | 0.76 | CA1 (0.30) | — | |
| SCHEMBL9844194 | 0.75 | — | — | |
| SCHEMBL9844189 | 0.75 | — | — | |
| SCHEMBL7757711 | 0.74 | — | — | |
| SCHEMBL28652400 | 0.74 | CA1 (0.33) | — | |
| SCHEMBL2788449 | 0.74 | — | — | |
| SCHEMBL2788447 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112300313-B | Ultrahigh-thickening multicolor dispersed phase emulsion and preparation method and application thereof | 衡水新光新材料科技有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-112300313-B | Ultrahigh-thickening multicolor dispersed phase emulsion and preparation method and application thereof | 衡水新光新材料科技有限公司 | 2023-01-17 | — | — | CN | disclosed |
| US-9586945-B2 | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2017-03-07 | — | — | US | disclosed |
| US-9365512-B2 | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2016-06-14 | — | — | US | disclosed |
| US-9238619-B2 | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2016-01-19 | — | — | US | disclosed |
| US-9067871-B2 | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-06-30 | — | — | US | disclosed |
| US-9051280-B2 | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20150111867-A1 | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-04-23 | — | — | US | disclosed |
| US-8957089-B2 | Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-02-17 | — | — | US | disclosed |
| US-8883839-B2 | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy | ABBOTT LABORATORIES (US) | 2014-11-11 | — | — | US | disclosed |
| US-20100184981-A1 | 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES | CLARK RICHARD | 2010-07-22 | — | — | US | disclosed |
| US-20090270433-A1 | 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090131480-A1 | Dihydropyridine Compounds for Neurodegenerative Diseases and Dementia | EISAI CO., LTD. (JP) | 2009-05-21 | — | — | US | disclosed |
| EP-1042004-A4 | METHOD FOR TISSUE PERFUSION | DIRECT THERAPEUTICS INC (US) | 2004-08-25 | — | — | EP | disclosed |
| US-6753005-B1 | DELIVERING AN ANTINEOPLASTIC AGENT TO A NORMAL OR NON-NEOPLASTIC SOLID TISSUE; BCNU | DIRECT THERAPEUTICS, INC. | 2004-06-22 | — | — | US | disclosed |
| EP-1042004-A1 | METHOD FOR TISSUE PERFUSION | Direct Therapeutics, Inc. (US) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999033492-A9 | METHOD FOR TISSUE PERFUSION | DIRECT THERAPEUTICS INC (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999033492-A1 | METHOD FOR TISSUE PERFUSION | DIRECT THERAPEUTICS, INC. (US) | 1999-07-08 | — | — | WO | disclosed |
| US-4167502-A | COPOLYMER OF UNSATURATED ACID AND AN ALLYL (METH)ACRYLATE | ROHM AND HAAS COMPANY (US) | 1979-09-11 | — | — | US | disclosed |
| US-4085167-A | POLYMERS OF AN ACRYLIC ACID AND AN OLIGOMER OF AN ALLYL-CONTAINING ACRYLIC ESTER | ROHM AND HAAS COMPANY (US) | 1978-04-18 | — | — | US | disclosed |